Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV -1.01%82 Receivables Turnover is 0.97 as of Apr. 2026. GuruFocus rates VEEV with a GF Score™ of 82/100 and a GF Value™ of $288.89 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 660 Healthcare Providers & Services companies, Veeva Systems ranks worse than 68.18% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Veeva Systems's Revenue for the
three
months ended in Apr. 2026 was $883 Mil. Veeva Systems's average Accounts Receivable for the
three
months ended in Apr. 2026 was $914 Mil.
Hence, Veeva Systems's Receivables Turnover for the
three
months ended in Apr. 2026 was 0.97.
Veeva Systems (NYSE:VEEV) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Veeva Systems Receivables Turnover Related Terms
Veeva Systems Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VEEV vs BTSG, TEM, HQY: Receivables Turnover Comparison
For the Health Information Services subindustry, Veeva Systems's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a Receivables Turnover of 0.97 as of Apr. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Veeva Systems and its competitors. According to the industry distribution chart, Veeva Systems ranks #450 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 68.2%.
Is Veeva Systems' Receivables Turnover too high?
Veeva Systems' current Receivables Turnover is 0.97. The Healthcare Providers & Services industry median Receivables Turnover is 7.75. Veeva Systems' value of 0.97 is 87.5% below this industry median. Based on the distribution chart, Veeva Systems ranks #450 out of 660 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Veeva Systems has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Receivables Turnover compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #450 out of 660 companies for Receivables Turnover. This places Veeva Systems in the lower half of its industry. The industry median Receivables Turnover is 7.75. Veeva Systems' value of 0.97 is 87.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Receivables Turnover of 0.97 is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Receivables Turnover is 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $288.89, compared to a current price of $195.38 — trading 32.4% below its estimated fair value. The current Receivables Turnover is 0.97 and 87.5% below the Healthcare Providers & Services industry median of 7.75. Veeva Systems' overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Veeva Systems (VEEV), the current Receivables Turnover is 0.97 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $195.38 is trading 32.4% below its estimated GF Value™ of $288.89.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
Receivables Turnover: 0.97
GF Value™: $288.89 vs. price of $195.38 (32.4% below fair value)
Industry Position: 87.5% below the Healthcare Providers & Services median (#450 of 660)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
82GF Score
Get the complete analysis for VEEV
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
